Načítá se...
How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
• A correct patient risk stratification is of paramount importance for the proper management of economic and human resources. • Clinical trials are crucial to assessing immunosuppressant prophylaxis and treatment to avoid overuse and treatment shortage. • Controlled studies may highlight a potential...
Uloženo v:
| Vydáno v: | Autoimmun Rev |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Published by Elsevier B.V.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7200131/ https://ncbi.nlm.nih.gov/pubmed/32376399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.autrev.2020.102574 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|